Frailty and low utilization of curative-intent surgical resection in non-metastatic pancreatic cancer

JNCI Cancer Spectrum · Published 2026-07-27 · DOI 10.1093/jncics/pkag078

Free full text

Authors (9)

Lauren Raymond-King, Sean McGrath, Bhramar Mukherjee, Yiran Wang, Harsh Parikh, John Rothen, Pamela R Soulos, Cary P Gross, John W Kunstman

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Raymond-King, L., McGrath, S., Mukherjee, B., et al. (2026). Frailty and low utilization of curative-intent surgical resection in non-metastatic pancreatic cancer. JNCI Cancer Spectrum. https://doi.org/10.1093/jncics/pkag078

Related articles

• Y-box binding protein-1 at the crossroads of DNA damage response and tumor immune evasion · JNCI Cancer Spectrum · 2026 · Same journal
• Luteinizing hormone-releasing hormone in prostate cancer treatment: from hypothalamic discovery to clinical translation · JNCI Cancer Spectrum · 2026 · Same journal
• Computational identification of salient cancer care topics and themes in oncology social work notes · JNCI Cancer Spectrum · 2026 · Same journal
• Trends in adult exclusive and dual use of combustible and non-combustible tobacco products in the United States · JNCI Cancer Spectrum · 2026 · Same journal
• Sociodemographic trends in prostate cancer: Insights from the all of Us research program · JNCI Cancer Spectrum · 2026 · Same journal
• Feasibility evaluation of a virtual lifestyle intervention for early-stage breast cancer survivors undergoing chemotherapy · JNCI Cancer Spectrum · 2026 · Same journal
• Clinical outcomes in pediatric acute lymphoblastic leukemia using modified BFM-95 protocol: 10-year study in Mexico City · JNCI Cancer Spectrum · 2026 · Same journal
• Emergency cancer diagnosis in older adults: patterns, subgroups, and implications for health-care quality metrics · JNCI Cancer Spectrum · 2026 · Same journal
• Contrastive multimodal deep learning for survival prediction in grade 2/3 gliomas · JNCI Cancer Spectrum · 2026 · Same journal
• Bone and soft tissue sarcoma mortality in 19 811 patients diagnosed in Japan, 2006-2020 · JNCI Cancer Spectrum · 2026 · Same journal